Saturday 17 October 2026
Export PASW’s income statement to Excel — free account
Ping An Biomedical Co., Ltd.
PASW Consumer Cyclical Textile Manufacturing
Ping An Biomedical Co., Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $4.8 million, down 61.6% from fiscal 2024.
0.12
0.01
−7.69%
Follow PASW
| Mar '26 | Sep '25 | Mar '25 | Sep '24 | |
|---|---|---|---|---|
Current Ratio |
2.54 | 2.76 | 0.77 | 0.84 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
9.98% | 14.76% | 21.16% | 18.40% |
Debt/Equity |
0.13 | 0.22 | (0.88) | (1.46) |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
0.16 | (0.90) | 0.03 | 2.09 |
Working Capital |
4.91 | 5.71 | (1.93) | (1.46) |
Capital Expenditures |
— | 0.00 | — | 0.00 |
Net Current Asset Value |
4.91 | 5.69 | (1.97) | (1.53) |
| Other line items | ||||
Quick Ratio |
1.91 | 2.32 | 0.54 | 0.64 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Capex per Share |
— | 0.00 | — | 0.00 |
Capex to Sales |
— | 0.00 | — | 0.00 |
Columns are period end dates